Researchers get $5.8 million NIH grant to fight drug-resistant microbes
UC Berkeley researchers will receive $5.8 million over five years from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to develop tools to quickly spot and identify drug-resistant pathogens. Read the full story here. Read the NIAID press release here.
- Published in stories
Emmunify: a vaccination tracking initiative
Emmunify is a simple tool for increasing vaccination coverage rates, created with the help of CEND-affiliated professor, Julia Walsh. The tool strives to improve medical record keeping and launching patient notification technology to ensure every child has a chance at a healthy life. The prototype was tested in slums of New Delhi and needs support for
- Published in stories
CEND-affiliated professor, Sarah Stanley, named 2014 Searle Scholar
Searle Scholars Program 2014 Press Release: Fifteen Searle Scholars Named for 2014 April 4, 2014: Chicago, Illinois – Fifteen researchers in the chemical and biological sciences have been named as the 2014 Searle Scholars. Each will be awarded $300,000 to support his or her work during the next three years. Since the program’s inception in
Diagnostics and Global Health Experts Meet at Diagnostics by Design Workshop
On January 9, 2014, the PoCDx IdeaLab, Tekla Labs, and the Henry Wheeler Center for Emerging & Neglected Diseases (CEND) hosted a workshop on the design, development, and implementation of global health technologies. The event attracted over 100 attendees from academia, industry, and the non-profit sector. Videos from the keynote speakers and panel discussion are available
Diagnostics by Design: A Hack Day for Global Health
On January 11 and 12th, 2014, the Henry Wheeler Center for Emerging and Neglected Diseases (CEND), Tekla Labs, and the Invention Lab @ CITRIS hosted a unique hack-a-thon on the UC Berkeley campus, “Diagnostics by Design: a hack day for global health.” The Diagnostics by Design hackathon was designed as a cross-communities effort to bridge
UC Berkeley Discovery Leads to Malaria Drug
Twelve years after a breakthrough at UC Berkeley, a discovery from the laboratory of Dr. Jay Keasling will finally be reaching those in need. On April 11, 2013, Sanofi launched production of semi-synthetic artemisinin, a key ingredient in the current gold standard for malaria treatment. Read the full story at the UC Berkeley News Center.
Understanding Health Disparities at Home and Abroad
The UC Berkeley Minority Health/Global Health (MH/GH) Training Program aims to provide international research experience and training in the health sciences and public health for undergraduate and graduate students committed to reducing U.S. and international health disparities. The program is largely built on the philosophy that providing underrepresented students with the opportunity to bring knowledge